Armata Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Denali Therapeutics (DNLI) and Armata Pharmaceuticals (ARMP)
Buy Rating Affirmed for Armata Pharmaceuticals Amid Progress in Bacteriophage Therapy Development
Armata Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Maintains $7 Price Target
Buy Rating Affirmed for Armata Pharmaceuticals Amid Clinical Progress and Strategic Growth
Robust Advancements and Strategic Planning: Key Drivers for Armata Pharmaceuticals' Buy Rating
Ladenburg Thalmann & Co. Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals Analyst Ratings
H.C. Wainwright Remains a Buy on Armata Pharmaceuticals (ARMP)
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target
H.C. Wainwright Sticks to Its Buy Rating for Armata Pharmaceuticals (ARMP)
H.C. Wainwright Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target
H.C. Wainwright Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)
H.C. Wainwright Remains a Buy on Armata Pharmaceuticals (ARMP)
Analysts Offer Insights on Healthcare Companies: Armata Pharmaceuticals (ARMP) and Clearside Biomedical (CLSD)
H.C. Wainwright Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP)
No Data